Babylon announced Thursday, the digital health company has hired Andrew Hine as vice president of the market marketing team for Asia, Europe, the Middle East and Africa.
The company said it will manage Babylon’s contracts and partnerships and work to increase its offerings and services in those regions. Hine joined Babylon from Ernst & Young, where he was head of the medical department for the Middle East and North Africa. He has previously worked at KPMG and the NHS, where he served as NHS chief executive and trust board director.
“I have been fortunate to work on the front lines of healthcare delivery and in different health systems in many countries. Addressed and potential for care models, processes and processes. and new technology to dramatically improve the quality, accessibility and cost of care,” Hine said in a statement.
Babylon to the community in 2021. Company revenue growth report boosted by its value-based care segment in the second quarter of this year but also recorded a loss of $157.1 million. Last week, Babylon said its shareholders had approved a reverse stock split aimed at preventing the company from being delisted from the New York Stock Exchange. Its shares have been selling for less than $1.00 for more than 30 days.
Healthcare data analytics platform Komodo Health appointed Lauren Stahl as vice president and head of sales.
Stahl has been with Komodo for more than three years, most recently as vice president of healthcare business. They have also served as the head of customer success at Datavant and are the founders and CEOs of Sparkite, a company focused on the treatment of stimulant use disorders.
Dr Aswin Chandrakantan, chief executive officer of Komodo Health, said in a statement: “Lauren has demonstrated an exceptional track record in strengthening customer relationships and unlocking markets and sales channels. new for customers. “As Komodo continues to invest in its end-to-end technology platform, having Lauren lead our sales team will only further accelerate our efforts to bring the best in technology. of Komodo and patient-centric insights for life sciences organizations, payers, government organizations, and more.”
Woebot Healthmaker of a mental health chatbot, has named Brad Gescheider its commercial director.
Most recently, Gescheider was the global head of digital innovation and patient services for Sanofi’s immunology business. He has also worked at Constant Therapy Health, GE Healthcare, McKesson and BNLikeMe.
“Brad’s understanding of the dynamics that shape today’s patient experience and his versatile background in many healthcare settings will be a key asset as we look to make tools Mental health and digital therapies are accessible to anyone who needs them,” Woebot CEO Michael Evers said in a statement. “As we expand and activate our strategic partnerships, Brad brings a wonderful combination of compassion and experience at this pivotal time in our growth.”
Woebot has been building its leadership team this year. It recently rented a finance director and a vice president of legal science and strategy.
Home diagnostic company Cue Health appointed Suzanne Stone as commercial director.
The company said Stone will lead Cue’s global commercial strategy and build a successful sales and customer team. She previously served as senior vice president of US revenue at Dexcom.
Ayub Khattak, President and CEO of Cue Health said: “Suzanne is a respected commercial leader with a wealth of healthcare experience and an impressive track record in building great teams. great”. “We aim to accelerate growth in key customer categories and strengthen our position as a leading healthcare technology company by delivering a seamless and consistent brand experience. under Suzanne’s competent leadership.”
Cue, best known for at-home molecular COVID-19 testing, also public debut in 2021. The company plans to expand the number of its Cue Reader-compatible tests. Like some other digital health and health technology companies so far this year, Cue recent layoff notice.
